000 01362 a2200397 4500
005 20250511122426.0
264 0 _c19790725
008 197907s 0 0 eng d
022 _a0002-953X
024 7 _a10.1176/ajp.136.6.762
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLehmann, H
245 0 0 _abeta-Endorphin and naloxone in psychiatric patients: clinical and biological effects.
_h[electronic resource]
260 _bThe American journal of psychiatry
_cJun 1979
300 _a762-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdrenocorticotropic Hormone
_xblood
650 0 4 _aAdult
650 0 4 _aChronic Disease
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aEndorphins
_xadministration & dosage
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNaloxone
_xtherapeutic use
650 0 4 _aProlactin
_xblood
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aSchizophrenia
_xblood
650 0 4 _aStress, Psychological
_xblood
700 1 _aNair, N P
700 1 _aKline, N S
773 0 _tThe American journal of psychiatry
_gvol. 136
_gno. 6
_gp. 762-6
856 4 0 _uhttps://doi.org/10.1176/ajp.136.6.762
_zAvailable from publisher's website
999 _c246319
_d246319